Abstract:ObjectiveTo investigate current practice, management and awareness of pediatric off-label drug use in China, and provide a reference for the effective management on pediatric off-label drug use.MethodsIt was a cross-sectional study.Pediatricians, pharmacists, nurses and medical section staffs from hospitals with pediatric qualification in 31 provinces of mainland China were recruited in the present study.An online anonymous questionnaire was designed by expert group of pediatricians, pharmacists, epidemiologists and pharmacy administration experts.The questionnaire consisted of 3 sections.The first section focused on participants'' general information (6 questions).The second section focused on practice and management of off-label drug use in the participants'' units (11 questions).The third section focused on awareness of medical professionals regarding off-label drug use and the Chinese Expert Consensus of Pediatric Off-Label Drug Use (33 questions).Results2 116 questionnaires were collected from 436 hospitals from 31 provinces including 36 specialized children''s hospitals, 50 maternal and child health hospitals and 350 general hospitals.The 436 hospitals comprised 20 primary hospitals, 185 secondary hospitals and 231 tertiary hospitals.2 116 respondents included 621pediatricians, 755 pharmacists, 531 nurses and 209 medical section staffs.63.8% of the pediatricians had off-label drug prescription experience and 18.8% of the pediatricians prescribed off-label drugs often.Pediatricians with higher technical titles prescribed off-label drugs more frequently.19.4% of the pediatricians were not reminded by pharmacists or nurses during the prescription.It was common for pharmacists to find off-label prescription regardless of the professional title (87.1%~98.3%) and hospital grade (82.1%~94.2%).6.9%~8.8% of the nurses refused to executive off-label prescription.60.6% of the participating hospitals had established protocols for off-label use.The rates were higher in tertiary hospitals and specialized children''s hospitals.70% of the respondents felt it was not illegal to use off-label drugs.However, more than 80% of the respondents realized that there were potential risks to use off-label drugs.Pharmacists had the highest awareness rate of the "Expert Consensus of Pediatric Off-Label Drug Use" (56.8%).followed by pediatricians (51.2%), medical section staffs (45.4%) and nurses (35.8%).ConclusionPediatric off-label drug use is common in China and there exists gaps in the management of the issue.It is necessary to establish the national guidelines to regulate pediatric off-label drug use with Chinese national conditions and to strengthen the training of medical professional on using off-label drugs.

A Study of Current Medication of Sinupret Drops in Chinese Pediatric Patients

A multi-center survey on the application of antibacterial agents in Chinese children in 2019

The Efficacy and Safety of Sinupret Drops in Treatment of Acute Sinusitis

[Survey on Common Pediatric Drugs for Renal Diseases].

[Expert Consensus on the Diagnosis and Treatment of Chronic Sinusitis in Children].

Survey-based investigation into the current use of paediatric medicines and administration devices in China

Prevalence and Risk Factors of Self-Medication among the Pediatric Population in China: A National Survey

Selection and Application Opportunity of Antibiotics in Children with Respiratory Tract Infections

A Prospective Open-Label Study to Assess the Efficacy and Safety of a Herbal Medicinal Product (Sinupret) in Patients with Acute Rhinosinusitis

[Cross-sectional study of family drug stockpile and children medication in China]

A Computational Method to Quantitatively Measure Pediatric Drug Safety Using Electronic Medical Records

Introduction to the Database “efficacy of Different Treatment Modalities for Lower Respiratory Tract Infections in Children”

Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial

Analysis of Outpatient Off-label Use in the Third Hospital of Peking University

Model-based exploration of the rationality of off-label use of cetirizine in Chinese pediatric patients: a prospective cohort study

Outpatient Antibiotic Prescribing Patterns in Children among Primary Healthcare Institutions in China: A Nationwide Retrospective Study, 2017–2019

Current practice, management and awareness of pediatric off-label drug use in China-A questionnaire based cross-sectional survey

Potentially inappropriate prescribing in hospitalised children: a retrospective, cross-sectional study at a tertiary children's hospital in China

Real-world data for the availability of pediatric medicines in Chinese hospitals: a multi-center survey and analysis

Pediatric drug development in China: Reforms and challenges

Antimicrobial prescribing for children in China: data from point prevalence surveys in 18 tertiary centres in China in 2016-2017